Raltegravir β-D-Glucuronide Methyl Ester-d3

• Catalog No.: R100322
• M. F.: C27H31FN6O11
• M. W.: 634.5670432

SYNONYMS

• IUPAC name: methyl (2S,3S,4S,5R,6S)-6-[(4-{[(4-fluorophenyl)methyl]carbamoyl}-1-(^2H₃)methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylate
• IUPAC Traditional name: methyl (2S,3S,4S,5R,6S)-6-[(4-{[(4-fluorophenyl)methyl]carbamoyl}-1-(^2H₃)methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxopyrimidin-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylate
• Synonyms: 4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-(1-methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl β-D-Glucopyranosiduronic Acid Methyl Ester

PROPERTIES

• Apperance: White Solid
• Solubility: Chloroform
• Solubility: Dichloromethane
• Solubility: Methanol

DETAILS

Description (English)

Protected, labelled metabolite of Raltegravir.